The Atlanta-based company focuses on licensing, developing, and commercializing products for pediatric medicine, including ZINOTIC and ZINOTIC ES for Acute Otitis Externa, NEOTIC for pain and inflammation associated with Acute Otitis Media, and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Arbor also offers the Pediaderm HC Complete Kit for children with atopic dermatitis. The company markets its products through specialty sales forces in the United States. In addition to pediatric medicine, Arbor develops prescription products for the cardiovascular, hospital, and neuroscience markets. The company prides itself on its experienced team and speed of execution in decision-making and implementation. Arbor is also committed to being a good corporate citizen by sponsoring nonprofit organizations that fund the discovery of new medicines or help people afflicted by diseases that their products treat.